87 related articles for article (PubMed ID: 23252995)
1. A field usable qualitative anti-protective antigen enzyme-linked immunosorbent assay for serodiagnosis of human anthrax.
Ghosh N; Tomar I; Goel AK
Microbiol Immunol; 2013 Feb; 57(2):145-9. PubMed ID: 23252995
[TBL] [Abstract][Full Text] [Related]
2. Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India.
Ghosh N; Goel AK
Clin Vaccine Immunol; 2012 Aug; 19(8):1238-42. PubMed ID: 22718130
[TBL] [Abstract][Full Text] [Related]
3. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
Quinn CP; Semenova VA; Elie CM; Romero-Steiner S; Greene C; Li H; Stamey K; Steward-Clark E; Schmidt DS; Mothershed E; Pruckler J; Schwartz S; Benson RF; Helsel LO; Holder PF; Johnson SE; Kellum M; Messmer T; Thacker WL; Besser L; Plikaytis BD; Taylor TH; Freeman AE; Wallace KJ; Dull P; Sejvar J; Bruce E; Moreno R; Schuchat A; Lingappa JR; Martin SK; Walls J; Bronsdon M; Carlone GM; Bajani-Ari M; Ashford DA; Stephens DS; Perkins BA
Emerg Infect Dis; 2002 Oct; 8(10):1103-10. PubMed ID: 12396924
[TBL] [Abstract][Full Text] [Related]
4. An ELISA using a recombinant chimera of protective antigen and lethal factor for serodiagnosis of cutaneous anthrax in India.
Varshney A; Puranik N; Kumar M; Pal V; Padmaja J; Goel AK
Biologicals; 2019 Jan; 57():55-60. PubMed ID: 30635155
[TBL] [Abstract][Full Text] [Related]
5. Development & validation of a quantitative anti-protective antigen IgG enzyme linked immunosorbent assay for serodiagnosis of cutaneous anthrax.
Ghosh N; Gunti D; Lukka H; Reddy BR; Padmaja J; Goel AK
Indian J Med Res; 2015 Aug; 142(2):196-204. PubMed ID: 26354217
[TBL] [Abstract][Full Text] [Related]
6. Serodiagnosis of human cutaneous anthrax in India using an indirect anti-lethal factor IgG enzyme-linked immunosorbent assay.
Ghosh N; Tomar I; Lukka H; Goel AK
Clin Vaccine Immunol; 2013 Feb; 20(2):282-6. PubMed ID: 23269414
[TBL] [Abstract][Full Text] [Related]
7. Qualification and performance characteristics of a quantitative enzyme-linked immunosorbent assay for human lgG antibodies to anthrax lethal factor antigen.
Selinsky CL; Whitlow VD; Smith LR; Kaslow DC; Horton HM
Biologicals; 2007 Apr; 35(2):123-9. PubMed ID: 17071101
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.
Quinn CP; Dull PM; Semenova V; Li H; Crotty S; Taylor TH; Steward-Clark E; Stamey KL; Schmidt DS; Stinson KW; Freeman AE; Elie CM; Martin SK; Greene C; Aubert RD; Glidewell J; Perkins BA; Ahmed R; Stephens DS
J Infect Dis; 2004 Oct; 190(7):1228-36. PubMed ID: 15346332
[TBL] [Abstract][Full Text] [Related]
9. Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.
Semenova VA; Steward-Clark E; Stamey KL; Taylor TH; Schmidt DS; Martin SK; Marano N; Quinn CP
Clin Diagn Lab Immunol; 2004 Sep; 11(5):919-23. PubMed ID: 15358653
[TBL] [Abstract][Full Text] [Related]
10. Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.
Semenova VA; Schmidt DS; Taylor TH; Li H; Steward-Clark E; Soroka SD; Ballard MM; Quinn CP
Vaccine; 2007 Feb; 25(10):1780-8. PubMed ID: 17229495
[TBL] [Abstract][Full Text] [Related]
11. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.
Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Snawder JE; Robertson SA; Quinn CP
Clin Vaccine Immunol; 2006 May; 13(5):541-6. PubMed ID: 16682473
[TBL] [Abstract][Full Text] [Related]
12. The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine.
Lininger LA; Cullum ME; Lyles MB; Bienek DR
Vaccine; 2007 Feb; 25(9):1619-25. PubMed ID: 17150286
[TBL] [Abstract][Full Text] [Related]
13. Detection of protective antigen, an anthrax specific toxin in human serum by using surface plasmon resonance.
Ghosh N; Gupta N; Gupta G; Boopathi M; Pal V; Goel AK
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):14-9. PubMed ID: 23773677
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.
Biagini RE; Sammons DL; Smith JP; MacKenzie BA; Striley CA; Semenova V; Steward-Clark E; Stamey K; Freeman AE; Quinn CP; Snawder JE
Clin Diagn Lab Immunol; 2004 Jan; 11(1):50-5. PubMed ID: 14715544
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical and serological findings for diagnosis of cutaneous anthrax infection after an outbreak.
Gulseren D; Süzük-Yıldız S; Çelebi B; Kılıç S
Cutan Ocul Toxicol; 2017 Sep; 36(3):289-293. PubMed ID: 28076993
[TBL] [Abstract][Full Text] [Related]
17. Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assays.
Brady RA; Verma A; Meade BD; Burns DL
Clin Vaccine Immunol; 2010 Sep; 17(9):1390-7. PubMed ID: 20631338
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.
Bienek DR; Chang CK; Cohen ME
Vaccine; 2007 Aug; 25(32):5978-84. PubMed ID: 17597265
[TBL] [Abstract][Full Text] [Related]
19. Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine.
Gubbins MJ; Schmidt L; Tsang RS; Berry JD; Kabani A; Stewart DI
J Immunoassay Immunochem; 2007; 28(3):213-25. PubMed ID: 17613668
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of an enzyme-linked immunosorbent assay based on a recombinant SpaA protein (rSpaA415) for detection of anti-Erysipelothrix spp. IgG antibodies in pigs.
Giménez-Lirola LG; Xiao CT; Halbur PG; Opriessnig T
J Microbiol Methods; 2012 Oct; 91(1):191-7. PubMed ID: 22766325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
